CoChat
Sign Up
Cited by 19Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsMaternal and Neonatal Healthcare

A Systematic Review of the Prevalence of Gestational Diabetes in Norway

Open access
Behboudi-Gandevani, Samira, Parajuli, Ranjan, Vaismoradi, Mojtaba·2021·International Journal of Environmental Research and Public Health
DOI 10.3390/ijerph18041423PMC PMC7913746
Open this paper in CoChat — free accountOpen PDF

Abstract

Gestational diabetes mellitus (GDM) is a major public health problem and a threat to maternal and child health. There is a lack of integrated and systematically synthesized knowledge about the prevalence GDM in Norway. Therefore, this systemic review aimed to present the best available peer-reviewed published evidence from the past 20 years about the prevalence of GDM in Norway. A comprehensive literature search was performed on online databases consisting of PubMed (including Medline), Web of Science, and Scopus to retrieve original research articles published on the prevalence of GDM up to August 2020. Also, databases of Norart and SveMed+ in the Norwegian language were searched to enhance the search coverage. Data were extracted using a standardized protocol and data collection form and were presented narratively. A total of 11 studies were selected to include for data analysis and synthesis with the total sample size of 2,314,191 pregnant women. The studies included heterogenous populations and mostly reported the prevalence of GDM in healthy mothers with singleton pregnancies. The prevalence of GDM in population registered-based studies in Norway was reported to be lower than 2%, using the World Health Organization (WHO) 1999 criteria. However, studies on high-risk populations such as the non-European ethnicity reported prevalence rates ranging from 8% to 15%. Given the evidence from available literature that reported trends in the prevalence of GDM, an increase in the prevalence of GDM across most racial/ethnic groups studied in Norway was observed. Overall, the prevalence of GDM in the low risk population of Norway is fairly low, but the available literature supports the perspective that the prevalence of GDM has shown an increasing trend in recent decades. This finding is very important for health service planning and evaluation, policy development, and research in Norway. Large-scale prospective studies, using the national data, are warranted to provide firm evidence over coming years. Our review findings can help policy makers devise appropriate strategies for improving women’s reproductive health.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijerph18041423

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is a lack of systematically synthesized and integrated data on GDM incidence in Norway.

    “There is a lack of systematically synthesized and integrated data on the GDM incidence in Norway [175].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [175]

    The Abstract states that integrated, systematically synthesized knowledge about GDM prevalence in Norway was lacking. The citing sentence substitutes incidence for prevalence; the paper’s stated gap does not establish a lack of synthesized incidence data. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. [1]Saravanan P. Diabetes in Pregnancy Working Group Maternal Medicine Clinical Study Group Royal College of Obstetricians Gestational diabetes: Opportunities for improving maternal and child health Lancet Diabetes Endocrinol. 2020 8 793 800 10.1016/S2213-8587(20)30161-3 32822601 · DOI
  2. [2]American Diabetes Association 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2020 Diabetes Care 2020 43 S14 S31 10.2337/dc20-S002 31862745 · DOI · Paper page
  3. [3]Behboudi-Gandevani S. Amiri M. Yarandi R.B. Tehrani F.R. The impact of diagnostic criteria for gestational diabetes on its prevalence: A systematic review and meta-analysis Diabetol. Metab. Syndr. 2019 11 1 18 10.1186/s13098-019-0406-1 30733833 PMC6359830 · DOI · Paper page
  4. [8]Catalano P.M. Trying to understand gestational diabetes Diabet. Med. 2014 31 273 281 10.1111/dme.12381 24341419 PMC4178541 · DOI · Paper page
  5. [10]Sonagra A.D. Biradar S.M. Dattatreya K. DS J.M. Normal Pregnancy—A State of Insulin Resistance J. Clin. Diagn. Res. 2014 8 CC01–3 10.7860/JCDR/2014/10068.5081 25584208 PMC4290225 · DOI · Paper page
  6. [11]Domanski G. Lange A.E. Ittermann T. Allenberg H. Spoo R.A. Zygmunt M. Heckmann M. Evaluation of neonatal and maternal morbidity in mothers with gestational diabetes: A population-based study BMC Pregnancy Childbirth 2018 18 1 11 10.1186/s12884-018-2005-9 30200916 PMC6131836 · DOI
  7. [12]Vounzoulaki E. Khunti K. Abner S.C. Tan B.K. Davies M.J. Gillies C.L. Progression to type 2 diabetes in women with a known history of gestational diabetes: Systematic review and meta-analysis BMJ 2020 369 m1361 10.1136/bmj.m1361 32404325 PMC7218708 · DOI · Paper page
  8. [14]Xu Y. Shen S. Sun L. Yang H. Jin B. Cao X. Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis PLoS ONE 2014 9 e87863 10.1371/journal.pone.0087863 24498216 PMC3909287 · DOI · Paper page
  9. [16]McMahon L.E. O’Malley E.G. Reynolds C.M.E. Turner M.J. The impact of revised diagnostic criteria on hospital trends in gestational diabetes mellitus rates in a high income country BMC Health Serv. Res. 2020 20 1 11 10.1186/s12913-020-05655-y PMC7449010 32843025 · DOI · Paper page
  10. [17]Ferrara A. Increasing Prevalence of Gestational Diabetes Mellitus: A public health perspective Diabetes Care 2007 30 S141 S146 10.2337/dc07-s206 17596462 · DOI · Paper page
  11. [18]Brown F.M. Wyckoff J. Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes Curr. Diabetes Rep. 2017 17 1 13 10.1007/s11892-017-0922-z 28799123 PMC5552830 · DOI · Paper page
  12. [19]Fadl H.E. Simmons D. Trends in diabetes in pregnancy in Sweden 1998–2012 BMJ Open Diabetes Res. Care 2016 4 e000221 10.1136/bmjdrc-2016-000221 27547412 PMC4985983 · DOI
  13. [25]Borgen I. Garnweidner-Holme L. Jacobsen A.F. Fayyad S. Småstuen M.C. Lukasse M. Knowledge of gestational diabetes mellitus at first consultation in a multi-ethnic pregnant population in the Oslo region, Norway—A cross-sectional study Ethn. Health 2019 2019 1 14 10.1080/13557858.2019.1655530 31416352 · DOI
  14. [26]Jenum A.K. Mørkrid K. Sletner L. Vangen S. Torper J.L. Nakstad B. Voldner N. Rognerud-Jensen O.H. Berntsen S. Mosdøl A. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: A population-based cohort study Eur. J. Endocrinol. 2012 166 317 324 10.1530/EJE-11-0866 22108914 PMC3260695 · DOI
  15. [27]Moher D. Liberati A. Tetzlaff J. Altman D.G. PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement BMJ 2009 339 b2535 10.1136/bmj.b2535 19622551 PMC2714657 · DOI · Paper page
  16. [29]Clausen T. Øyen N. Henriksen T. Pregnancy complications by overweight and residential area. A prospective study of an urban Norwegian cohort Acta Obstet. Gynecol. Scand. 2006 85 526 533 10.1080/00016340500523644 16752229 · DOI
  17. [30]Engeland A. Bjørge T. Daltveit A.K. Skurtveit S. Vangen S. Vollset S.E. Furu K. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway Eur. J. Epidemiol. 2011 26 157 163 10.1007/s10654-010-9527-4 21298469 PMC3043244 · DOI
  18. [31]Helseth R. Salvesen Ø. Stafne S.N. Mørkved S. Salvesen K.Å. Carlsen S.M. Gestational diabetes mellitus among Nordic Caucasian women: Prevalence and risk factors according to WHO and simplified IADPSG criteria Scand. J. Clin. Lab. Investig. 2014 74 620 628 10.3109/00365513.2014.928942 24980704 · DOI
  19. [32]Leirgul E. Brodwall K. Greve G. Vollset S.E. Holmstrøm H. Tell G.S. Øyen N. Maternal Diabetes, Birth Weight, and Neonatal Risk of Congenital Heart Defects in Norway, 1994–2009 Obstet. Gynecol. 2016 128 1116 1125 10.1097/AOG.0000000000001694 27741197 · DOI
  20. [33]Strøm-Roum E.M. Tanbo T. Eskild A. The associations of maternal body mass index with birthweight and placental weight. Does maternal diabetes matter? A population study of 106 191 pregnancies Acta Obstet. Gynecol. Scand. 2016 95 1162 1170 10.1111/aogs.12947 27454190 · DOI
  21. [34]Sørbye L.M. Skjaerven R. Klungsøyr K. Morken N.-H. Gestational diabetes mellitus and interpregnancy weight change: A population-based cohort study PLoS Med. 2017 14 e1002367 10.1371/journal.pmed.1002367 28763446 PMC5538633 · DOI
  22. [35]Lekva T. Godang K. Michelsen A.E. Qvigstad E. Normann K.R. Norwitz E.R. Aukrust P. Henriksen T. Bollerslev J. Roland M.C.P. Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks’ Gestation Sci. Rep. 2018 8 13392 10.1038/s41598-018-31614-z 30190548 PMC6127333 · DOI
  23. [36]Leeves L.T. Andreasen C. Marrable S. Glasø M.U. Rostad M.-K. Olsen I.P. Bjørnerem Å. Prevalens av diabetes blant gravide og svangerskapsutfall i Nordland og Troms 2004–15 Tidsskr. Den Nor. Legeforening 2019 139 10.4045/tidsskr.18.0927 31823575 · DOI
  24. [37]Sørbye I.K. Daltveit A.K. Sundby J. Vangen S. Preterm subtypes by immigrants’ length of residence in Norway: A population-based study BMC Pregnancy Childbirth 2014 14 239 10.1186/1471-2393-14-239 25048200 PMC4223612 · DOI
  25. [38]Bakken K.S. Skjeldal O.H. Stray-Pedersen B. Obstetric Outcomes of First- and Second-Generation Pakistani Immigrants: A Comparison Study at a Low-Risk Maternity Ward in Norway J. Immigr. Minor. Health 2015 19 33 40 10.1007/s10903-015-0329-3 26706470 · DOI
  26. [39]Poolsup N. Suksomboon N. Amin M. Effect of Treatment of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis PLoS ONE 2014 9 e92485 10.1371/journal.pone.0092485 24658089 PMC3962411 · DOI
  27. [40]Lavery J.A. Friedman A.M. Keyes K.M. Wright J.D. Ananth C.V. Gestational diabetes in the United States: Temporal changes in prevalence rates between 1979 and 2010 BJOG: Int. J. Obstet. Gynaecol. 2017 124 804 813 10.1111/1471-0528.14236 PMC5303559 27510598 · DOI · Paper page
  28. [41]Zhu Y. Zhang C.-L. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: A Global Perspective Curr. Diabetes Rep. 2016 16 1 11 10.1007/s11892-015-0699-x 26742932 PMC6675405 · DOI · Paper page
  29. [42]Buckley B.S. Harreiter J. Damm P. Corcoy R. Chico A. Simmons D. Vellinga A. Dunne F. on behalf of the DALI Core Investigator group Gestational diabetes mellitus in Europe: Prevalence, current screening practice and barriers to screening. A review Diabet. Med. 2012 29 844 854 10.1111/j.1464-5491.2011.03541.x 22150506 · DOI · Paper page
  30. [43]Nijs H. Benhalima K. Gestational Diabetes Mellitus and the Long-Term Risk for Glucose Intolerance and Overweight in the Offspring: A Narrative Review J. Clin. Med. 2020 9 599 10.3390/jcm9020599 32098435 PMC7074239 · DOI
  31. [44]Billionnet C. Mitanchez D. Weill A. Nizard J. Alla F. Hartemann A. Jacqueminet S. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 Diabetologia 2017 60 636 644 10.1007/s00125-017-4206-6 28197657 PMC6518373 · DOI
  32. [45]Miao M. Dai M. Zhang Y. Sun F. Guo X. Sun G. Influence of maternal overweight, obesity and gestational weight gain on the perinatal outcomes in women with gestational diabetes mellitus Sci. Rep. 2017 7 1 8 10.1038/s41598-017-00441-z 28331199 PMC5428436 · DOI · Paper page
  33. [46]Kuo C.-H. Chen S.-C. Fang C.-T. Nien F.-J. Wu E.-T. Lin S.-Y. Chuang L.-M. Lee C.-N. Li H. Screening gestational diabetes mellitus: The role of maternal age PLoS ONE 2017 12 e0173049 10.1371/journal.pone.0173049 28296923 PMC5351872 · DOI
  34. [47]Hedderson M.M. Darbinian J.A. Ferrara A. Disparities in the risk of gestational diabetes by race-ethnicity and country of birth Paediatr. Périnat. Epidemiol. 2010 24 441 448 10.1111/j.1365-3016.2010.01140.x 20670225 PMC4180530 · DOI
  35. [48]Pu J. Zhao B. Wang E.J. Nimbal V. Osmundson S. Kunz L. Popat R.A. Chung S. Palaniappan L.P. Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors Paediatr. Périnat. Epidemiol. 2015 29 436 443 10.1111/ppe.12209 26201385 PMC6519933 · DOI

Cited by

Sorted by citations

Authors
Behboudi-Gandevani, S., Parajuli, R., & Vaismoradi, M.
Affiliations
  • Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, Norway
  • Nord University (NO)
ORCID
Venue
International Journal of Environmental Research and Public Health
Publisher
MDPI AG
Published
2021-02-03
Volume
18
Issue
4
Pages
1423
ISSN
1660-4601 (ISSN-L)
DOI
10.3390/ijerph18041423
PMC
PMC7913746
OpenAlex
W3129113499
Cited by
19
References
8
Citations by year
2026: 4 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 2
FWCI
0.64
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
  • Charles Sturt University Research Output (CRO) (submittedVersion, cc-by)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
Nord universitet
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Health Professions › General Health Professions › Maternal and Neonatal Healthcare
Keywords
gestational diabetes mellitus, prevalence, Norway, ethnic minority women, prevalence trends, maternal health, health policy
MeSH terms
Child, Female, Humans, Norway, Pregnancy, Prospective Studies, Risk Factors, Prevalence, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review